Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma

被引:10
|
作者
Jinato, Thananya [1 ,2 ]
Anuntakarun, Songtham [1 ]
Satthawiwat, Nantawat [1 ]
Chuaypen, Natthaya [1 ]
Tangkijvanich, Pisit [1 ]
机构
[1] Chulalongkorn Univ, Fac Med, Ctr Excellence Hepatitis & Liver Canc, Dept Biochem, Bangkok 10330, Thailand
[2] Chulalongkorn Univ, Fac Med, Philosophy Program Med Sci, Grad Affairs, Bangkok, Thailand
关键词
Gut dysbiosis; HCC; Viral hepatitis; NAFLD; 16 s rRNA; Biomarker; FATTY LIVER-DISEASE; INTESTINAL MICROBIOME; METAANALYSIS; ALCOHOL;
D O I
10.1007/s00253-023-12845-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Altered gut microbiota has been connected to hepatocellular carcinoma (HCC) occurrence and advancement. This study was conducted to identify a gut microbiota signature in differentiating between viral-related HCC (Viral-HCC) and non-hepatitis B-, non-hepatitis C-related HCC (NBNC-HCC). Fecal specimens were obtained from 16 healthy controls, 33 patients with viral-HCC (17 and 16 cases with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, respectively), and 18 patients with NBNC-HCC. Compositions of fecal microbiota were assessed by 16S rRNA sequencing. Bioinformatic analysis was performed by the DADA2 pipeline in the R program. Significantly different genera from the top 50 relative abundance were used to classify between subgroups of HCC by the Random Forest algorithm. Our data demonstrated that the HCC group had a significantly decreased alpha-diversity and changed microbial composition in comparison with healthy controls. Within the top 50 relative abundance, there were 11 genera including Faecalibacterium, Agathobacter, and Coprococcus that were significantly enhanced in Viral-HCC, while 5 genera such as Bacteroides, Streptococcus, Ruminococcus gnavus group, Parabacteroides, and Erysipelatoclostridium were enhanced in NBNC-HCC. Compared to Viral-HCC, the NBNC-HCC subgroup significantly reduced various short-chain fatty acid-producing bacteria, as well as declined fecal butyrate but elevated plasma surrogate markers of microbial translocation. Based on the machine learning algorithm, a high diagnostic accuracy to classify HCC subgroups was achieved with an area under the receiver-operating characteristic (ROC) curve (AUC) of 0.94. Collectively, these data revealed that gut dysbiosis was distinct according to etiological factors of HCC, which might play an essential role in hepatocarcinogenesis. These findings underscore the possible use of a gut microbiota signature for the diagnosis and therapeutic approaches regarding different subgroups of HCC. Key points center dot Gut dysbiosis is connected to hepatocarcinogenesis and can be used as a novel biomarker. center dot Gut microbiota composition is significantly altered in different etiological factors of HCC. center dot Microbiota-based signature can accurately distinguish between Viral-HCC and NBNC-HCC.
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条
  • [41] ALTERATION IN GUT MICROBIOTA ASSOCIATED WITH HEPATITIS B AND NON-HEPATITIS VIRUS RELATED HEPATOCELLULAR CARCINOMA
    Liu, Qisha
    Li, Fan
    Zhuang, Yaoyao
    Xu, Jian
    Zhang, Yewei
    Liu, Xingyin
    GASTROENTEROLOGY, 2019, 156 (06) : S1271 - S1271
  • [42] Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma
    Liu, Qisha
    Li, Fan
    Zhuang, Yaoyao
    Xu, Jian
    Wang, Jianwei
    Mao, Xuhua
    Zhang, Yewei
    Liu, Xingyin
    GUT PATHOGENS, 2019, 11 (1)
  • [43] Clinico-radiological profile of Non Alcoholic Fatty liver Disease related Hepatocellular Carcinoma: Comparison With Hepatocellular Carcinoma of Viral Etiology
    Paul, Shashi
    Swami, Sonu
    Nadda, Neeti
    Nayak, Baibaswata
    Shalimar, S.
    Acharya, Subrat
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 575 - 575
  • [44] Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
    Zhang, Xinhe
    Guan, Lin
    Tian, Haoyu
    Zeng, Zilu
    Chen, Jiayu
    Huang, Die
    Sun, Ji
    Guo, Jiaqi
    Cui, Huipeng
    Li, Yiling
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma
    An, Ping
    Xu, Jinghang
    Yu, Yanyan
    Winkler, Cheryl A.
    FRONTIERS IN GENETICS, 2018, 9
  • [46] CLINICAL PREDICTORS OF MORTALITY IN HEPATOCELLULAR CARCINOMA OF NON-VIRAL AETIOLOGY
    Niriella, Madunil A.
    Siriwardana, Rohan C.
    Dassanayake, Anuradha S.
    De Silva, Arjuna P.
    Gunathillake, Bhagya
    Pathmeswaran, Arunasalam
    de Silva, Hithanadura J.
    GASTROENTEROLOGY, 2017, 152 (05) : S1180 - S1180
  • [47] Inflammatory Milieu Related to Dysbiotic Gut Microbiota Promotes Tumorigenesis of Hepatocellular Carcinoma
    Huang, Caizhi
    Mei, Si
    Zhang, Xue
    Tian, Xuefei
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (08) : 782 - 788
  • [48] Letter on "Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular Carcinoma"
    Qian, Da
    Wu, Chaoshen
    Tao, Danhao
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [49] Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non-viral infection: A Japanese multicenter observational study
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Hiraoka, Atsushi
    Tada, Toshifumi
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Shimada, Noritomo
    Kawata, Kazuhito
    Kosaka, Hisashi
    Tanaka, Takaaki
    Ohama, Hideko
    Nouso, Kazuhiro
    Morishita, Asahiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Okubo, Tomomi
    Arai, Taeang
    Imai, Michitaka
    Naganuma, Atsushi
    Koizumi, Yohei
    Nakamura, Shinichiro
    Joko, Kouji
    Kaibori, Masaki
    Iijima, Hiroko
    Hiasa, Yoichi
    Kumada, Takashi
    CANCER MEDICINE, 2023, 12 (05): : 5293 - 5303
  • [50] VALIDATION OF CRAFITY SCORE IN VIRAL AND NON-VIRAL HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Huang, Kuo Wei
    Lee, Pei-Chang
    Wu, Chi-Jung
    Chao, Yee
    Lee, I-Cheng
    Hung, Yi-Ping
    Chen, San-Chi
    Huang, Yi-Hsiang
    HEPATOLOGY, 2022, 76 : S1398 - S1399